X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $17.23 | -10,295 | 156,920 | -6% | -$177,383 | ||||||
2023-07-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $18.01 | -22,321 | 167,215 | -12% | -$401,981 | ||||||
2023-03-30 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $26.52 | -11,245 | 145,786 | -7% | -$298,228 | ||||||
2023-01-23 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $34.48 | -67,500 | 76,926 | -47% | -$2,327,630 | ||||||
2022-12-20 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $19.10 | -10,887 | 144,426 | -7% | -$207,968 | ||||||
2022-10-25 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $25.05 | -5,000 | 133,437 | -4% | -$125,241 | ||||||
2022-07-11 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $20.00 | -3,000 | 138,436 | -2% | -$60,000 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |